Shojaei F, Erfanifar A, Kalbasi S, Nikpour S, Gachkar L
BMC Endocr Disord. 2025; 25(1):52.
PMID: 40011855
PMC: 11863618.
DOI: 10.1186/s12902-025-01882-8.
Ahmad R, Haque M
Cureus. 2024; 16(10):e71730.
PMID: 39421288
PMC: 11486535.
DOI: 10.7759/cureus.71730.
Asadi A, Rostami M, Shafiee R, Ardalani A, Dehghanitafti A, Golshadi Z
Arch Endocrinol Metab. 2024; 68:e230216.
PMID: 39420901
PMC: 11460970.
DOI: 10.20945/2359-4292-2023-0216.
Yang Z, Li A, Jiang Y, Maidaiti X, Wu Y, Jin Y
Sci Rep. 2024; 14(1):22232.
PMID: 39333707
PMC: 11437073.
DOI: 10.1038/s41598-024-72795-0.
Zhang M, Zhao W, Zhang Z, He M, Zhang Y, Song B
BMC Endocr Disord. 2024; 24(1):164.
PMID: 39210356
PMC: 11360499.
DOI: 10.1186/s12902-024-01705-2.
Diabetes mellitus and the risk of spontaneous bacterial peritonitis in patients with liver cirrhosis: a systematic review and meta-analysis.
Alhajaji R, Samkari M, Althobaiti M, Al-Ahmadi B, Bugis A, Bugis A
Ann Saudi Med. 2024; 44(4):272-287.
PMID: 39127903
PMC: 11316951.
DOI: 10.5144/0256-4947.2024.272.
Associations between type 2 diabetes mellitus and chronic liver diseases: evidence from a Mendelian randomization study in Europeans and East Asians.
Zhao Y, Li D, Shi H, Liu W, Qiao J, Wang S
Front Endocrinol (Lausanne). 2024; 15:1338465.
PMID: 38495785
PMC: 10941029.
DOI: 10.3389/fendo.2024.1338465.
Proanthocyanidins-Based Synbiotics as a Novel Strategy for Nonalcoholic Fatty Liver Disease (NAFLD) Risk Reduction.
Thilakarathna W, Rupasinghe H
Molecules. 2024; 29(3).
PMID: 38338453
PMC: 10856248.
DOI: 10.3390/molecules29030709.
Non-Alcoholic Fatty Liver Disease Is Associated with a Decreased Catalase (CAT) Level, CT Genotypes and the T Allele of the -262 C/T Polymorphism.
Kosmalski M, Szymczak-Pajor I, Drzewoski J, Sliwinska A
Cells. 2023; 12(18).
PMID: 37759451
PMC: 10527641.
DOI: 10.3390/cells12182228.
Type 2 Diabetes Mellitus, Non-Alcoholic Fatty Liver Disease, and Metabolic Repercussions: The Vicious Cycle and Its Interplay with Inflammation.
Frankowski R, Kobierecki M, Wittczak A, Rozycka-Kosmalska M, Pietras T, Sipowicz K
Int J Mol Sci. 2023; 24(11).
PMID: 37298632
PMC: 10254034.
DOI: 10.3390/ijms24119677.
Non-Alcoholic Fatty Liver Disease or Type 2 Diabetes Mellitus-The Chicken or the Egg Dilemma.
Kosmalski M, Sliwinska A, Drzewoski J
Biomedicines. 2023; 11(4).
PMID: 37189715
PMC: 10135804.
DOI: 10.3390/biomedicines11041097.
Nanoplastics Toxicity Specific to Liver in Inducing Metabolic Dysfunction-A Comprehensive Review.
Haldar S, Yhome N, Muralidaran Y, Rajagopal S, Mishra P
Genes (Basel). 2023; 14(3).
PMID: 36980862
PMC: 10048484.
DOI: 10.3390/genes14030590.
The association of dietary inflammatory index (DII) and central obesity with non-alcoholic fatty liver disease (NAFLD) in people with diabetes (T2DM).
Soltanieh S, Salavatizadeh M, Poustchi H, Yari Z, Mansour A, Khamseh M
Heliyon. 2023; 9(3):e13983.
PMID: 36915483
PMC: 10006473.
DOI: 10.1016/j.heliyon.2023.e13983.
Identifying advanced MAFLD in a cohort of T2DM and clinical features.
Sanchez-Bao A, Soto-Gonzalez A, Delgado-Blanco M, Balboa-Barreiro V, Bellido D
Front Endocrinol (Lausanne). 2023; 14:1058995.
PMID: 36909342
PMC: 9992874.
DOI: 10.3389/fendo.2023.1058995.
What's New in the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD).
Kosmalski M, Frankowski R, Ziolkowska S, Rozycka-Kosmalska M, Pietras T
J Clin Med. 2023; 12(5).
PMID: 36902639
PMC: 10003344.
DOI: 10.3390/jcm12051852.
Significant Association between Subclinical Left Cardiac Dysfunction and Liver Stiffness in Metabolic Syndrome Patients with Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease.
Apostu A, Malita D, Arnautu S, Tomescu M, Gaita D, Popescu A
Medicina (Kaunas). 2023; 59(2).
PMID: 36837528
PMC: 9961822.
DOI: 10.3390/medicina59020328.
Pharmacological Support for the Treatment of Obesity-Present and Future.
Kosmalski M, Deska K, Bak B, Rozycka-Kosmalska M, Pietras T
Healthcare (Basel). 2023; 11(3).
PMID: 36767008
PMC: 9914730.
DOI: 10.3390/healthcare11030433.
(Pro)Renin Receptor Antagonism Attenuates High-Fat-Diet-Induced Hepatic Steatosis.
Gayban A, A C Souza L, Cooper S, Regalado E, Kleemann R, Earley Y
Biomolecules. 2023; 13(1).
PMID: 36671527
PMC: 9855393.
DOI: 10.3390/biom13010142.
The association of fatty liver index and BARD score with all-cause and cause-specific mortality in patients with type 2 diabetes mellitus: a nationwide population-based study.
Chung G, Jeong S, Cho E, Yoon J, Yoo J, Cho Y
Cardiovasc Diabetol. 2022; 21(1):273.
PMID: 36474232
PMC: 9727979.
DOI: 10.1186/s12933-022-01691-6.
Rech. f. Mediated Fabrication of Gold Nanoparticles; Characterization and Evaluation of Antimicrobial, Antioxidant and Antidiabetic Potency of the Synthesized AuNPs.
Jamil S, Dastagir G, Foudah A, Alqarni M, Yusufoglu H, Alkreathy H
Molecules. 2022; 27(19).
PMID: 36235206
PMC: 9572856.
DOI: 10.3390/molecules27196669.